Sentinel Node With Ultrasound Contrast in Melanoma

This study has been completed.
Sponsor:
Information provided by:
Rigshospitalet, Denmark
ClinicalTrials.gov Identifier:
NCT00370136
First received: August 29, 2006
Last updated: June 17, 2008
Last verified: June 2008
  Purpose

The purpose is to evaluate,in 20 patients, if the sentinel node(s) in melanoma can be detected by lymph contrast ultrasound. In comparing the patients will also get lymph-scintigraphy and sentinel node detection wiht blue dye.

The goal is to improve the method for detecting sentinel node(s) in melanoma.


Condition Intervention
Malignant Melanoma
Drug: ultrasound contrast

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Single Blind
Primary Purpose: Diagnostic
Official Title: Sentinel Node Diagnostics With Ultrasound Contrast in Melanoma

Resource links provided by NLM:


Further study details as provided by Rigshospitalet, Denmark:

Estimated Enrollment: 20
Study Start Date: August 2006
Estimated Study Completion Date: April 2008
Estimated Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Malignant melanoma on a extremity,
  • No spread of the cancer,
  • Patients over 18 years old,

Exclusion Criteria:

  • Pregnancy,
  • Lactating,
  • Severe hart disease,
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00370136

Locations
Denmark
Copenhagen univercity hospital, Department of Radiology, section of ultrasound
Copenhagen, Denmark, 2100
Sponsors and Collaborators
Rigshospitalet, Denmark
Investigators
Principal Investigator: Michael B Nielsen, MDSc Department of Radiology, section ultrasound
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00370136     History of Changes
Other Study ID Numbers: (KF)01288200
Study First Received: August 29, 2006
Last Updated: June 17, 2008
Health Authority: Denmark: The Danish National Committee on Biomedical Research Ethics

Additional relevant MeSH terms:
Melanoma
Neuroendocrine Tumors
Neuroectodermal Tumors
Neoplasms, Germ Cell and Embryonal
Neoplasms by Histologic Type
Neoplasms
Neoplasms, Nerve Tissue
Nevi and Melanomas

ClinicalTrials.gov processed this record on August 27, 2014